Sort
46,585 grants matching “heart failure”
Plasma Metabolomics and Myocardial Energetics in Heart Failure
$805,320David E Lanfear · Henry Ford Health System · R01 · FY2017 · HL
Arterial Elasticity, Subclinical, and Clinical CVD in MESA
$805,314David R Jacobs · University Of Minnesota · R01 · FY2010 · HL
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
$805,268Wanpen Vongpatanasin · Ut Southwestern Medical Center · R01 · FY2023 · HL
Elucidating the structural insights into the BMP receptor mutations in PAH
$805,232Akiko Hata · University Of California, San Francisco · R01 · FY2023 · HL
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL
$805,220Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2019 · HL
A micromachining fluidic cantilever for single cell advanced patch clamping and cellular characterization using atomic force microscopy
$805,173Ami Chand · Applied Nanostructures, Inc. · R44 · FY2023 · GM
FHFs and Cardiac Electrophysiology
$805,152Glenn I Fishman · New York University School Of Medicine · R01 · FY2021 · HL
Calcium Pump Activators for Heart Failure Therapy
$805,140David Dale Thomas · University Of Minnesota · R01 · FY2018 · HL
Washington University AsthmaNet
$805,134Mario Castro · Washington University · U10 · FY2010 · HL
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
$805,115Wanpen Vongpatanasin · Ut Southwestern Medical Center · R01 · FY2025 · HL
BiVACOR Rotary Total Artificial Heart
$805,079Daniel Timms · Bivacor, Inc. · R44 · FY2018 · HL
Molecular Regulation of Cardiovascular 7 TM Receptors
$804,984Robert J Lefkowitz · Duke University · R01 · FY2019 · HL
Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease
$804,781Marylyn D Ritchie · University Of Pennsylvania · R01 · FY2023 · HL
Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease
$804,720Lipika Samal · Brigham And Women'S Hospital · R01 · FY2019 · DK
Targeted inhibition of fibrosis for the prevention of heart failure
$804,648Jason R. McCarthy · Massachusetts General Hospital · R01 · FY2015 · HL
Application of Machine Learning to Identify Obstructive Sleep Apnea Subgroups at Risk for Atherosclerosis Progression and Cardiovascular Disease Events (OSA-GRANDE)
$804,477Neomi A Shah · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
Phenotyping Net Immune State with MicroRNAs in Cardiac Transplantation
$804,438Palak Shah · Inova Health Care Services · R01 · FY2025 · HL
Hypertension Pharmacogenetics
$804,308Julie A. Johnson · University Of Florida · R01 · FY2006 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE
$804,221Johns Hopkins University · U01 · FY2001 · HL
Improving Outcomes after Pediatric Cardiac Arrest
$804,145Robert Michael Sutton · Children'S Hosp Of Philadelphia · R01 · FY2016 · HL
Impact of Interventions on Future Trends in Subnational Burden of Cardiovascular Diseases in the US
$803,986Gregory Andrew Roth · University Of Washington · R01 · FY2022 · HL
Improving Outcomes after Pediatric Cardiac Arrest
$803,941Robert Michael Sutton · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Development of a Magnetically Driven Heart Pump
$803,912Kurt A Dasse · Thoratec, Llc · R44 · FY2007 · HL
Hypo-immunogenic cardiomyocytes for myocardial repair
$803,909Tobias Deuse · University Of California, San Francisco · R01 · FY2019 · HL
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial
$803,813Linda Ruth Peterson · Washington University · R61 · FY2022 · HL